Back to GetFilings.com



Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


     
(Mark One)    
[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
For the quarterly period ended September 30, 2002
 
OR
 
[   ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the transition period from ____________ to ____________ .

Commission file number: 0-26811

NexPrise, Inc.

(Exact name of Registrant as specified in its charter)
   
Delaware
(State or other jurisdiction
of incorporation or organization)
77-0465496
(I.R.S. Employer
Identification Number)

5950 La Place Court, Suite 200
Carlsbad, CA 92008
760-804-1333

(Address, including zip code, and telephone
number, including area code, of Registrant’s principal
executive offices)

     Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes  [X]    No  [   ]

     On September 30, 2002, 3,231,954 shares of the registrant’s common stock, $.0002 par value per share, were issued and outstanding.



 


TABLE OF CONTENTS

CONDENSED CONSOLIDATED BALANCE SHEETS
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Qualitative and Quantitative Disclosure about Market Risk
Item 4. Controls and Procedures
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
Item 2. Changes in Securities and Use of Proceeds
Item 3. Defaults upon Senior Securities
Item 4. Submission of Matters to a Vote of Securities Holders
Item 5. Other Information
Item 6. Exhibits and Reports on Form 8-K
SIGNATURE
CERTIFICATIONS
EXHIBIT INDEX
EXHIBIT 99.1
EXHIBIT 99.2


Table of Contents

NEXPRISE, INC.
FORM 10-Q

TABLE OF CONTENTS

         
        Page
       
    PART I FINANCIAL INFORMATION  
Item 1.   Unaudited Condensed Consolidated Financial Statements:  
    Balance Sheets as of September 30, 2002 and December 31, 2001     3
    Statements of Operations for the Three and Nine Months Ended September 30, 2002 and 2001     4
    Statements of Cash Flows for the Nine Months Ended September 30, 2002 and 2001     5
    Notes to Condensed Consolidated Financial Statements     7
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations   14
Item 3.   Qualitative and Quantitative Disclosure about Market Risk   25
Item 4.   Controls and Procedures   26
 
    PART II OTHER INFORMATION  
Item 1.   Legal Proceedings   26
Item 2.   Changes in Securities and Use of Proceeds   27
Item 3.   Defaults Upon Senior Securities   27
Item 4.   Submission of Matters to a Vote of Securities Holders   27
Item 5.   Other Information   27
Item 6.   Exhibits and Reports on Form 8-K   27
SIGNATURE   28
CERTIFICATIONS   29
EXHIBIT INDEX   31

2


Table of Contents

NEXPRISE, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)
                                     
            September 30,   December 31,
            2002   2001
            (unaudited)   (1)
           
 
ASSETS
               
Current assets:
               
 
Cash and cash equivalents
  $ 1,925     $ 13,565  
 
Short-term investments
    9,400       8,150  
 
Accounts receivable — net of reserves of $90 and $182
    445       760  
 
Other current assets
    2,684       1,406  
 
Current assets relating to discontinued operations
          290  
 
   
     
 
   
Total current assets
    14,454       24,171  
Restricted cash
          520  
Property and equipment, net
    698       2,675  
Equity investments
          3,033  
Goodwill
    11,652       11,652  
Other long-term assets, net
    11,185       10,574  
 
   
     
 
   
Total assets
  $ 37,989     $ 52,625  
 
   
     
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities:
               
 
Accounts payable
  $ 289     $ 665  
 
Accrued compensation
    517       960  
 
Accrued expenses
    3,117       5,400  
 
Deferred revenue
    771       525  
 
Other current liabilities
          114  
 
Accrued liabilities relating to discontinued operations
    341       715  
 
   
     
 
   
Total current liabilities
    5,035       8,379  
Notes payable, less current portion
    11,843       8,803  
Commitments and contingencies
           
Stockholders’ equity:
               
 
Preferred stock, no par value 2,500 shares authorized: none issued or outstanding
           
 
Common stock, $.0002 par value; 175,000 shares authorized; 3,232 and 3,087 shares issued and outstanding
    10       10  
 
Additional paid-in capital
    631,907       631,082  
 
Deferred compensation
    (620 )     (592 )
 
Accumulated deficit
    (610,340 )     (595,130 )
 
Accumulated other comprehensive income
    154       73  
 
   
     
 
   
Total stockholders’ equity
    21,111       35,443  
 
   
     
 
   
Total liabilities and stockholders’ equity
  $ 37,989     $ 52,625  
 
   
     
 

(1)  Derived from December 31, 2001 audited financial statements

See accompanying notes to condensed consolidated financial statements.

3


Table of Contents

NEXPRISE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)
(Unaudited)
                                             
      Three Months Ended   Nine Months Ended
      September 30,   September 30,
     
 
      2002   2001   2002   2001
     
 
 
 
Net revenues
  $ 728     $ 350     $ 2,055     $ 350  
Cost of revenues
    628       265       1,810       265  
 
   
     
     
     
 
 
Gross profit
    100       85       245       85  
Operating expenses:
                               
 
Research and development
    1,044       3,280       4,403       22,072  
 
In process research and development
          2,300       399       2,300  
 
Sales and marketing
    1,274       1,648       4,534       8,962  
 
General and administrative
    1,117       2,506       4,297       11,903  
 
Restructuring and settlement charges
          5,299             19,949  
 
   
     
     
     
 
 
Total operating expenses
    3,435       15,033       13,633       65,186  
 
   
     
     
     
 
Operating loss
    (3,335 )     (14,948 )     (13,388 )     (65,101 )
Interest expense
    (190 )     (190 )     (559 )     (5,421 )
Interest income and other, net
    63       495       157       4,212  
Investment gain/ losses, net
    1,060       (1,948 )     (1,420 )     (8,174 )
 
   
     
     
     
 
Loss before extraordinary item
    (2,402 )     (16,591 )     (15,210 )     (74,484 )
Extraordinary item: gain from retirement of bonds, net
                      159,162  
 
   
     
     
     
 
Net income (loss)
  $ (2,402 )   $ (16,591 )   $ (15,210 )   $ 84,678  
 
   
     
     
     
 
Basic and diluted loss per share before extraordinary item
  $ (0.75 )   $ (5.38 )   $ (4.77 )   $ (24.19 )
Basic and diluted income per share from extraordinary item
  $     $     $     $ 51.70  
Basic and diluted net income (loss) per share
  $ (0.75 )   $ (5.38 )   $ (4.77 )   $ 27.50  
Weighted average common shares outstanding used in computing basic and diluted net income (loss) per share
    3,209       3,086       3,187       3,079  

See accompanying notes to condensed consolidated financial statements.

4


Table of Contents

NEXPRISE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)
(Unaudited)
                                 
          Nine Months Ended
          September 30,
         
    2002   2001
         
 
Operating Activities                
Net loss before extraordinary item
  $ (15,210 )   $ (74,484 )
Extraordinary item
          159,162  
Adjustments to reconcile net loss to net cash used in operating activities:
               
 
Depreciation and amortization
    1,347       5,855  
 
Amortization of intangible assets
    1,823       2,300  
 
Amortization of deferred stock-based compensation
    288       215  
 
Investment losses
    1,420       8,174  
 
Non-cash restructuring and settlement charges
          8,568  
 
Gain from retirement of convertible notes
          (159,162 )
 
Non-cash charges related to stock-option grants
    29       41  
Changes in operating assets and liabilities:
               
 
Accounts receivable
    315       1,014  
 
Other current assets
    (745 )     853  
 
Discontinued assets
    183       16,570  
 
Other long term assets
    (603 )     346  
 
Accounts payable
    (453 )     (542 )
 
Accrued compensation
    (473 )     (2,242 )
 
Accrued expenses
    (1,502 )     (11,236 )
 
Deferred revenue
    246       (13 )
 
Discontinued liabilities
    (374 )     (26,547 )
 
   
     
 
   
Net cash used in operating activities
    (13,709 )     (71,128 )
 
   
     
 
Investing Activities
               
Purchase of property and equipment
          (693 )
Purchases of short-term investments
    (24,601 )     (264,387 )
Maturities of short-term investments
    25,152       360,093  
(Increase)/decrease in restricted cash
    520       (3,564 )
Investment in vertical operating companies
          (6,000 )
Purchase of NexPrise, net of cash acquired
          (21,331 )
Cash acquired on purchase of InfoPrise
    1,029        
 
   
     
 
   
Net cash (used in) provided by investing activities
    2,100       64,118  
 
   
     
 
Financing Activities
               
Principal payments on and repurchases of notes payable
          (60,931 )
Principal payments on capital lease obligations and notes payable
    (114 )     (313 )
Issuance of common stock
    2       (37 )
   
Net cash used in financing activities
    (112 )     (61,281 )
 
   
     
 
Effect of foreign exchange rate changes
    81        
Net decrease in cash and cash equivalents
    (11,640 )     (68,291 )
Cash and cash equivalents at beginning of period
    13,565       91,348  
 
   
     
 
Cash and cash equivalents at end of period
  $ 1,925     $ 23,057  
 
   
     
 
Supplemental disclosure of noncash activities:
               
Note received upon sale of marketplace interest
  $     $ 11,000  
Note transferred upon retirement of convertible debt
          (11,000 )
Issuance of shares in connection with the acquisition of InfoPrise
    794        
Unrealized accounting loss on available-for-sale securities
          (735 )
Issuance of convertible notes relating to NexPrise acquisition
          1,236  
Deferred stock based compensation related to the stock options assumed in connection with the acquisition of NexPrise
          687  
Deferred stock based compensation related to the stock options assumed in connection with the acquisition of InfoPrise
    (316 )      
Issuance of convertible notes relating to InfoPrise acquisition
    3,040        

See accompanying notes to condensed consolidated financial statements.

5


Table of Contents

NEXPRISE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Unaudited

Note 1.    Description of Business

     NexPrise, Inc. (the “Company” or “NexPrise” or “we”), formerly known as Ventro Corporation and Chemdex Corporation, is a leading source for business process applications and provides solutions and services that enable discrete manufacturing companies to address their specific business challenges. These solutions complement and expand on currently installed enterprise systems and allow for the continuous process improvements required to meet customers’ changing business demands.

     As of September 30, 2002, the Company had working capital of approximately $9.4 million and stockholders’ equity of approximately $21.1 million. During the three months ended September 30, 2002 the Company used cash and cash equivalents in operating activities of approximately $4.1 million, which included an insurance prepayment of approximately $600,000. During the nine months ended September 30, 2002 the Company used cash and cash equivalents in operating activities of approximately $13.7 million. Management believes it has sufficient working capital to support the Company’s planned activities through 2002 and beyond.

Note 2.    Summary of Significant Accounting Policies

Basis of Presentation

     The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany accounts and transactions have been eliminated. While the quarterly financial information is unaudited, the financial statements included in this Form 10-Q reflect all adjustments (consisting of normal recurring adjustments) that the Company considers necessary for a fair presentation of the results of operations for the interim periods covered and of the financial condition of the Company at the date of the interim balance sheet. The results for the interim periods are not necessarily indicative of the results for the entire year. The condensed consolidated balance sheet as of December 31, 2001 has been derived from the audited consolidated balance sheet as of that date. The information included in this report should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ending December 31, 2001.

Revenue.

     NexPrise recognizes revenue for software subscriptions over the term of the subscription period. Revenue for services is recognized as the services are performed. Deferred revenue consists of that portion of customer contracts invoiced in advance of when the revenue will be recognized under the subscription method. Revenue is made up primarily of subscriptions of bundled licenses and post contract support (PCS) and in some situations includes hosting. The initial and renewal amounts are recognized as revenue ratably over the period of the license during which the services are expected to be provided.

     Our revenue recognition policy is in accordance with Statement of Position No. 97-2, or SOP 97-2, “Software Revenue Recognition,” as amended and Staff Accounting Bulletin No. 101. For each arrangement, we determine whether evidence of an arrangement exists, delivery has occurred, the fee is fixed or determinable, and collection is probable. If any of these criteria are not met, revenue recognition is deferred until such time as all of the criteria are met. Generally terms are net 30. No customer has the right of return. At this time, the Company does not present elements of revenue separately as allocation methodologies (i.e. allocation based on relative costs) would not provide a meaningful and supportable allocation principally because the Company has yet to establish sufficient vendor specific objective evidence among various elements.

Net Income (Loss) Per Share

     Net income (loss) per share is presented in accordance with the requirements of Statement of Financial Accounting Standards No. 128 “Earnings Per Share” (FAS 128) which requires dual presentation of basic earnings per share (“EPS”) and diluted EPS.

     Basic net income (loss) per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common shares and potentially dilutive shares outstanding during the period. The same number of common shares has been used to calculate per share amounts before extraordinary item and net income or loss in 2001 and 2002 in accordance with FAS 128 guidance based on the loss before

6


Table of Contents

extraordinary item. The financial data has been retroactively adjusted to reflect the 1-for-15 reverse stock split which became effective April 22, 2002.

Use of Estimates

     The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Concentration of Credit Risk and Significant Customers

     The Company’s customer base consists of businesses located primarily in North America. The Company maintains allowances for potential credit losses and historically, such losses have been within management’s expectations. Revenue and accounts receivable by customers comprising more than 10% of total amounts are as follows:

                                                             
    % of Total Revenues
   
  % of Net Accounts
    Three Months Ended   Six Months Ended   Receivable as of
   
 
 
    September 30,   September 30,   September 30,   December 31,
   
 
 
 
    2002   2001   2002   2001   2002   2001
   
 
 
 
 
 
Customer A
    14 %     13 %     14 %     13 %        
Customer B
    13 %     13 %     13 %     13 %         15 %
Customer C
    11 %         11 %            
Customer D
    10 %     12 %     11 %     12 %        
Customer E
                        10 %
Customer F
                    10 %    
Customer G
                    11 %    

Note 3.    Business Combinations

     In February 2002 NexPrise acquired privately held InfoPrise, Inc. (“InfoPrise”), a provider of data management solutions located in Carlsbad, California. As consideration for the acquisition, which was accounted for using the purchase method, NexPrise agreed to issue unsecured convertible promissory notes with a face value of $3,040,000 due 2007. The notes bear interest at a rate of 6% and are convertible into the Company’s common stock at $18.75 per share. The Company also issued 139,783 shares of NexPrise common stock and assumed InfoPrise’s outstanding stock options, which may result in the issuance of up to approximately 64,666 shares of NexPrise common stock. An independent valuation study was commissioned to value the intangible assets associated with the InfoPrise purchase and facilitate the purchase accounting.

     The following table summarizes the forms of consideration and their fair values (in thousands):

         
Convertible promissory note
  $ 3,040  
Restricted stock (92,565 shares)
    361  
Employee stock options assumed
    117  
Liabilities assumed and transaction costs
    125  
 
   
 
Total purchase consideration
  $ 3,643  
 
   
 

     A summary of the InfoPrise purchase transaction is shown below (in thousands):

         
Tangible assets
  $ 1,010  
Developed technology
    2,234  
In process research and development
    399  
 
   
 
 
  $ 3,643  
 
   
 

7


Table of Contents

     The following unaudited pro forma information shows the results of operations of the Company for the three and nine months ended September 30, 2002 and 2001 as if the business combinations with NexPrise and InfoPrise had occurred at the beginning of each period. In process research and development charges of $399,000 are included for the three and nine months ended September 30, 2002. This data is not indicative of the results of operations that would have arisen if the business combinations had occurred at the beginning of the respective periods and is not intended to be indicative of future results of operations (in thousands except per share data).

                                         
    Three Months Ended   Nine Months Ended
    September 30,   September 30,
   
 
    2002   2001   2002   2001
   
 
 
 
Revenue
  $ 728     $ 665     $ 2,055     $ 2,083  
Loss before extraordinary items
  $ (2,402 )   $ (22,066 )   $ (15,310 )   $ (89,086 )
Net income (loss)
  $ (2,402 )   $ (22,066 )   $ (15,310 )   $ 70,076  
Basic and diluted net loss per share before extraordinary item
  $ (0.75 )   $ (7.15 )   $ (4.80 )   $ (28.93 )
Basic and diluted net income (loss) per share:
  $ (0.75 )   $ (7.15 )   $ (4.80 )   $ 22.76  

The financial data has been retroactively adjusted to reflect the 1-for-15 reverse stock split which became effective April 22, 2002.

Note 4.    Comprehensive Income (Loss)

     Statement of Financial Accounting Standards No. 130, Reporting Comprehensive Income (SFAS 130), establishes standards of reporting and display of comprehensive income and its components of net income (loss) and “Other Comprehensive Income.” Other Comprehensive Income refers to revenues, expenses, gains and losses that are not included in net income (loss) but rather are recorded directly in stockholders’ equity. The components of comprehensive income (loss) for the three and nine months ended September 30, 2002 and 2001 were as follows (in thousands):

                                         
    Three Months Ended   Nine Months Ended
    September 30,   September 30,
   
 
    2002   2001   2002   2001
   
 
 
 
Net income (loss)
  $ (2,402 )   $ (16,591 )   $ (15,210 )   $ 84,678  
Unrealized gains (losses) on available for sale securities
          70             (665 )
Foreign exchange translation
    8             80        
 
   
     
     
     
 
Comprehensive Income (Loss)
  $ (2,394 )   $ (16,521 )   $ (15,130 )   $ 84,013  
 
   
     
     
     
 

8


Table of Contents

Note 5.    Balance Sheet Details

Other Current Assets

     Other current assets of $2.7 million and $1.4 million as of September 30, 2002 and December 31, 2001, respectively, are comprised primarily of prepaid expenses, prepaid royalties, current deposits and other receivables. During the second quarter of fiscal 2002 the Company entered into loan agreements totaling $75,000 with an executive and another member of the management team. The loans are full recourse, accrue interest at 6% per annum and are included in the other receivables mentioned above.

Other Long-term Assets

     Other long-term assets are comprised of the following (in thousands):

                         
      September 30,   December 31,
      2002   2001
     
 
Deposits and other
  $ 769     $ 746  
Purchased intangibles, net of accumulated amortization of $2,794 and 971 respectively
    9,638       8,829  
Deferred debt offering costs, net of accumulated amortization of $450 and 415 respectively
    165       200  
Long-term investments, cost method
    613       799  
 
   
     
 
 
Total other long-term assets
  $ 11,185     $ 10,574  
 
   
     
 

Note 6. Equity Investments

     The following table outlines the Company’s equity investment activity with its marketplace companies for the nine months ended September 30, 2001 and 2002 (in thousands):

                                                   
                                    Percentage
    Carrying Value at   Additional   Equity Loss of   Carrying Value at   Ownership at
Activity in 2001   December 31, 2000   Investment   Investee   September 30, 2001   September 30, 2001
   
 
 
 
 
Amphire
  $ 0     $ 2,000     $ 1,388     $ 612       36 %
MarketMile
    6,103       4,000       5,882       4,221       30 %
 
                                    Percentage
    Carrying Value at   Additional   Equity Loss of   Carrying Value at   Ownership at
Activity in 2002   December 31, 2001   Investment   Investee   September 30, 2002   September 30, 2002
   
 
 
 
 
Amphire
  $ 412           $ 412     $ 0       0 %
MarketMile
    2,621             2,621       0       23 %

     In the nine months ended September 30, 2001, the Company billed the affiliated marketplace companies approximately $3.7 million, net of reserves, and there were no billings in 2002. The billings were for charges incurred on behalf of the marketplace companies, services the Company provided and facility rent that we passed on to the marketplace companies.

Note 7.    Convertible Notes

     In February 2002 NexPrise issued unsecured, convertible promissory notes with a face value of $3,040,000, a conversion price of $18.75 and interest rate of 6% in connection with the acquisition of InfoPrise. The promissory notes are due in 2007 and are convertible into NexPrise’s common stock. As of September 30, 2002 no amount of the notes had been converted into NexPrise common stock. At September 30, 2002 and December 31, 2001, respectively, approximately $8.8 million of convertible subordinated

9


Table of Contents

notes issued April 2000 and due in 2007 remained outstanding. These convertible subordinated notes bear annual interest at 6% and are convertible at the option of the holder into the Company’s common stock at a price of $1,361.70 per share.

Note 8.    Contingencies

     In 2001, several class action lawsuits, including one derivative suit, were filed and served on the Company alleging that the Company and certain individuals made false and misleading statements concerning our business model and earnings for fiscal 2000. The Company is also a defendant in the IPO class action suits filed against issuers and the investment banks alleging that the offering documents were false and misleading. Although we believe that we have meritorious defenses to the actions and intend to defend the suits vigorously, we cannot predict with certainty the outcome of these lawsuits. Our defense against such lawsuits will be costly and will require a significant commitment of time and resources by our senior management. Although the Company has insurance to cover these claims, the recovery of all future costs is not assured. The Company has also been served with a stockholder derivative action but is named solely as a nominal defendant against whom no recovery is sought.

     One of our subtenants is attempting to renegotiate its sublease agreement with us. We have drawn upon the subtenant’s security deposit to cover our expenses and are working to resolve the issue with these subtenants or to find replacement tenants. If we are unable to successfully resolve this situation our sublease income may not be enough to pay what we may be liable for in ongoing lease payments. The Company has accrued for expected additional costs as a result of the potential loss of this sublease income.

     The Company is a party to various claims in the ordinary course of business. Although the results of litigation and claims cannot be predicted with certainty, the Company believes the final outcome of such matters will not have a material adverse effect on the Company’s financial position, results of operations or cash flows.

Discontinued Marketplace Companies Formerly Known as Promedix and Chemdex

     Contracts with Promedix and Chemdex customers and suppliers contained, in some cases, cancellation notification periods longer than the Company provided. In some cases, shorter notification periods caused inconvenience to customers and suppliers, and the Company has been notified by several suppliers that discontinuing the marketplace represents a breach of Promedix contractual obligations. Additionally, two customers of Chemdex have informed the Company that they did not receive notice of the termination of their contracts within the contractually required time period. However, as of September 30, 2002, no customer or supplier of Promedix or Chemdex had filed a formal complaint with the Company.

Government Regulations

     In addition to regulations applicable to businesses generally, the Company is or may be subject to direct regulation by governmental agencies which includes numerous laws and regulations generally applicable to the chemical, pharmaceutical, controlled substances, human and biological reagents, medical and in vitro devices, nuclear chemical businesses and environmental spills, as well as U.S. import and export controls and import controls of other countries. While the shutdown of Chemdex, Promedix and SpecialtyMD may limit future regulatory and product liability risks, until all statutes of limitation have expired, certain legal risks will remain.

     The Company relied on its suppliers to comply with applicable local, state and federal laws regarding the labeling and the dissemination of information on any products sold that may be hazardous or present a health threat to the user. If these suppliers have failed, or we have failed, to maintain the requisite records irrespective of the actions of the suppliers, or if either of us had failed to adequately comply with labeling and information dispensing requirements of local, state or federal laws, then the Company may be held legally responsible, since Company held title to these products, and could be subject to governmental penalties or fines, as well as private lawsuits to enforce these laws.

     Finally, the Company has relied upon its suppliers to obtain appropriate approvals for products regulated by the FDA and to comply with the requirements relating to those approvals and products. The failure of suppliers to obtain or comply with those approvals, or the failure of the product advertising or labeling to be consistent with the FDA approval for the products, or other failures by the products themselves, or our failure to keep regulatory records required by the FDA, such as complaint files, could result in costly product recalls, significant fines and judgments, civil and criminal liabilities and negative publicity.

10


Table of Contents

     In February, 2001 the Company received a subpoena from the U.S. Department of Justice, Drug Enforcement Administration, for certain billing, invoice, and shipping records concerning sales to an unaffiliated purchaser. Other than the foregoing, the Company is unaware of any current investigations, inquiries, citations, fines or allegations of violations or non-compliance relating to regulatory requirements pending by government agencies or by third parties against us. It is possible, however, that there may be such investigations or allegations that the Company is not aware of or future investigations or allegations. The risk that any noncompliance may be discovered in the future is currently unknown. Although any potential impact on the Company for noncompliance cannot currently be established, it could result in significant civil or criminal penalties, including monetary fines and injunctions, for noncompliance and negative publicity, and seriously harm our business, revenues, results of operations and financial condition.

Note 9.    Related Parties

     In fiscal 2001 the Company entered into a Net Proceeds Income Agreement with DDP Ventures, a company owned by our former Chief Executive Officer. Pursuant to the Net Proceeds Agreement, DDP Ventures is entitled to 10% of the net proceeds received by the Company for the liquidation of each of certain named investment assets. The Net Proceeds Income Agreement is filed as Exhibit Number 10.28.

     In the quarter ended September 30, 2002, the Company sold its interest in Amphire Solutions. The gain of $1.8 million reflects fees of approximately $200,000 paid to DDP Ventures.

Note 10.    Deferred Stock-Based Compensation

     In connection with the acquisition of InfoPrise completed in February 2002, the Company assumed the outstanding options granted under the InfoPrise stock option plans. The Company recorded deferred compensation of $132,293 for the difference between the exercise price of the unvested options assumed and the fair value of the common stock underlying those options as of the date the acquisition was consummated. That charge is being amortized over the remaining vesting period of the options. Additionally, the Company recorded deferred compensation of $184,178 with respect to the issuance of restricted common stock. That charge is being amortized over the remaining vesting period of the stock.

     The Company recognized $288,000 and $215,000 in stock compensation expense for the nine months ended September 30, 2002 and 2001, respectively.

Note 11.    Settlement, Restructuring and Other Charges

     During the year ended December 31, 2001, the Company took many actions to improve efficiencies and reduce operating costs. The specific actions include employee and contractor terminations, consolidation of facilities, settlements of various disputes and termination of leases. The net of these charges was reported as a component of loss before extraordinary item.

     At September 30, 2002 the Company had unliquidated accruals of approximately $547,000 related to settlement, restructuring and other activities. At June 30, 2002 the Company had unliquidated accruals of $436,000. In the three months ended September 30, 2002 the activity involving the settlement, restructuring and other accrual consisted primarily of restructuring charges of approximately $242,000 related to a reduction in force undertaken in September 2002, a $200,000 reduction of a charge initially accrued in December 2001 and the realization of additional cash proceeds of approximately $69,000 from the liquidation of excess equipment originally written off in the restructuring events of 2001.

Note 12.    Recent Accounting Pronouncements

     In July 2001, the Financial Accounting Standards Board (FASB) issued SFAS No. 141, Business Combinations, and SFAS No. 142, Goodwill and Other Intangible Assets. SFAS No. 141 requires that the purchase method of accounting be used for all business combinations initiated after June 30, 2001. SFAS No. 141 also specifies criteria for determining intangible assets acquired in a purchase method business combination that must be recognized and reported apart from goodwill, noting that any purchase price allocable to an assembled workforce may not be accounted for separately. SFAS No. 142 requires that goodwill and intangible assets with indefinite useful lives no longer be amortized, but instead be tested for impairment at least annually in accordance with the provisions of SFAS No. 142. SFAS No. 142 also requires that intangible assets with definite useful lives be amortized over their respective estimated useful lives to their estimated residual values, and reviewed for impairment in accordance with SFAS No. 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of. The Company adopted Statement

11


Table of Contents

142 in January 2002. Application of the non-amortization provisions of Statement 142 did not result in a change to results of operations in 2002 as there was no goodwill amortized in fiscal 2001. The Company has tested goodwill generated by the NexPrise and InfoPrise acquisitions using the two-step process prescribed in Statement 142. The first required step is a screen for potential impairment, while the second step measures the amount of the impairment, if any. The Company performed the first of the required impairment tests of NexPrise goodwill as of January 1, 2002 and did not have an impairment of the goodwill balance. The Company performed its required annual impairment test in September and again did not have an impairment of the goodwill balance. The Company plans to perform the required annual impairment test of the goodwill balance again in September 2003. However, if facts or circumstances change, and there are indicators of impairment a write down may be required before September 2003.

     In August, 2001, the FASB issued Statement of Financial Accounting Standards No. 144. “Accounting for the Impairment or Disposal of Long-Lived Assets” (“SFAS 144”) which is applicable to financial statements issued for fiscal years beginning after December 15, 2001. The FASB’s new rules on asset impairment supersede SFAS 121, “Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of,” and portions of Accounting Principles Board Opinion 30, “Reporting the Results of Operations.” This Standard provides a single accounting model for long-lived assets to be disposed of and significantly changes the criteria that would have to be met to classify an asset as held-for-sale. Classification as held-for-sale is an important distinction since such assets are not depreciated and are stated at the lower of fair value and carrying amount. This Standard also requires expected future operating losses from discontinued operations to be displayed in the period(s) in which the losses are incurred, rather than as of the measurement date as presently required. Our adoption of SFAS 144 on January 1, 2002 did not have a material effect on our operating results or financial condition.

     In July 2002 the FASB issued Statement of Financial Accounting Standards No. 146, “Accounting for Costs Associated with Exit or Disposal Activities” (“SFAS 146”). SFAS 146 addresses significant issues relating to the recognition, measurement and reporting of costs associated with exit and disposal activities, including restructuring activities, and nullifies the guidance in Emerging Issues Task Force (EITF) Issue No. 94-3, “Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring).” SFAS 146 requires that the initial liability for costs associated with exit and disposal activities be measured at fair value and prohibits the recognition of a liability based solely on an entity’s commitment to a plan. The provisions of SFAS 146 are effective for exit and disposal activities initiated after December 31, 2002. Retroactive application of SFAS 146 is prohibited and, accordingly, liabilities recognized prior to the initial application of SFAS 146 should continue to be accounted for in accordance with EITF 94-3 or other applicable pre-existing guidance. The Company does not believe that the adoption of SFAS 146 will have a material impact on its financial position or results of operations.

12


Table of Contents

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

     The following Management’s Discussion and Analysis of Results of Operations and Financial Condition contains forward-looking statements. In some cases, readers can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue.” These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from those stated herein. Although management of NexPrise believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance, or achievements. For further information, refer to Management’s Discussion and Analysis and the Risk Factors section of NexPrise’s Annual Report on Form 10-K and the section entitled “Investment Considerations” in this Form 10-Q.

Overview

     NexPrise, Inc. (the “Company”, “NexPrise”, “us”, “our” or “we”) formerly known as both Ventro Corporation and as Chemdex Corporation, is a leading source for business process applications and collaborative solutions for program management and quote management.

     In 2001 we significantly restructured our operations and focused on a new business direction. We exited the business of building and servicing business-to-business marketplaces and entered the business of providing collaborative and business process automation software solutions. In August 2001, while doing business under the name Ventro Corporation, we acquired privately-held NexPrise, Inc., a company with an advanced collaborative software solution and an established customer base located in Santa Clara, California. Later in the year we reorganized our management team and Board of Directors and took measures to reduce commitments and operating expenses and conserve cash. In 2001 the Company incurred a net charge of $16.5 million in connection with restructurings and settlements. In January 2002, we changed our name to NexPrise, Inc.

     On February 4, 2002 we acquired privately-held InfoPrise, Inc. (“InfoPrise”), a provider of data management solutions located in Carlsbad, California and are using the acquired technology to create a library of business process automation applications and tools. As consideration for the acquisition, we issued unsecured 6% convertible promissory notes, due in 2007, with a face value of $3,040,000 and a per share conversion price of $18.75, together with 139,783 shares of common stock and assumed InfoPrise’s outstanding stock options, which may result in the issuance of up to approximately 64,666 shares of common stock. All revenues presented are derived from the operations of the combination of NexPrise and InfoPrise. We expect to incur operating losses on a quarterly basis for at least the next twelve months as we develop and enhance our technology and service offerings.

Critical Accounting Policies

     General. Management’s discussion and analysis of its financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

     Management believes the following critical accounting policies affect its more significant estimates and assumptions used in the preparation of its consolidated financial statements.

     Revenue recognition. The Company recognizes license revenue using the “subscription” method. While many software providers recognize significant up-front license fees, the subscription method recognizes revenue ratably over the duration of a contract.

     Investments. The various interests that we have acquired in companies are accounted for under three broad methods: consolidation, the equity method and the cost method. The applicable accounting method is generally determined based on our voting interest in a company.

13


Table of Contents

          Consolidation. Companies that NexPrise directly or indirectly controls are accounted for under the consolidation method of accounting. Under this method, a company’s accounts are reflected within its Consolidated Financial Statements. All significant inter-company accounts and transactions are eliminated.

          Equity Method. Entities where NexPrise can exercise significant influence, but not control, are accounted for under the equity method of accounting. Whether or not NexPrise exercises significant influence with respect to a company depends on an evaluation of several factors including, among others, representation on the company’s board of directors and ownership level, generally 20% — 50% interest in the voting securities of the company including voting rights associated with NexPrise holdings in common, preferred and other convertible instruments in the company. Under the equity method of accounting, our share of the earnings or losses of these companies are included in the investment income (loss) section of the Consolidated Statements of Operations.

          Cost Method. Companies not consolidated or accounted for under the equity method are accounted for under the cost method of accounting. Under this method, NexPrise’s share of the earnings or losses of these companies is not included in its Consolidated Statements of Operations. The Company periodically evaluates the carrying value of its investments for impairment.

     The fair value of the long-term investments is dependent on the performance of the entities in which the Company has invested, as well as volatility inherent in the external markets for these investments. In assessing potential impairment for these investments the Company will consider these factors as well as forecasted financial performance of its investees. If these forecasts are not met the Company may have to record additional impairment charges not previously recognized.

     Long lived assets. The Company’s long-lived assets include goodwill and other intangible assets. At September 30, 2002, the Company had $21.3 million of goodwill and other intangible assets. In assessing the recoverability of the Company’s goodwill and other intangibles, the Company must make assumptions regarding estimated future cash flows and other factors to determine the fair value of the respective assets. If these estimates or their related assumptions change in the future, the Company may be required to record impairment charges for these assets not previously recorded. The Company performed the first of the required impairment tests of NexPrise goodwill as of January 1, 2002 and did not have an impairment of the goodwill balance. The Company performed its required annual impairment test in September 2002 and again did not have an impairment of the goodwill balance. Under SFAS 142, the fair value of the Company as represented by its stock price has a significant effect on the determination of any required writedown of goodwill and other tangible assets. The extent to which the Company’s stock price at the time of the next impairment test is lower than at other points in time in which the goodwill has been evaluated increases the probability of a writedown. The Company plans to perform the required impairment test of the goodwill balance again in September 2003. However, if facts or circumstances change, and there are indicators of impairment a write down may be required before September 2003.

Results of Operations

     Revenues. NexPrise reported $728,000 of revenue for the three months ended September 30, 2002 and $2.1 million for the nine months ended September 30, 2002. This revenue is made up primarily of subscriptions of bundled license and post contract support (PCS) and, in some cases, includes hosting for the Company’s collaborative commerce products. Subscription revenue generally entails recognizing the value of the customer contract as revenue ratably over the term of the contract. The revenue reported by NexPrise for the three and nine months ended September 30, 2001 reflects activity from the acquisition of NexPrise, Inc. on August 8, 2001 until September 30, 2001. Revenues are not expected to increase materially in the fourth quarter of 2002, but the Company plans for revenues to increase thereafter as existing customers expand their number of users and as new customers are brought under contract.

     Cost of revenues. Cost of revenues were $628,000 for the three months ended September 30, 2002 and $1.8 million for the nine months ended September 30, 2002. Of those amounts, approximately $221,000 and $662,000 respectively, represent non-cash amortization of the developed technology intangible asset acquired in the purchase of NexPrise in August 2001. The remainder consists of outsourced hosting services for our customers, personnel and other expenses associated with providing maintenance services, technical support services and royalties payable to third parties whose software is incorporated into the NexPrise solution. The Company expects cost of revenues to increase in the coming quarters as we begin to amortize the developed technology intangible asset acquired in the InfoPrise purchase in February 2002.

     Research and development. Research and development expenses for the three months ended September 30, 2002 were $1.0 million, a 68% decrease from the $3.3 million reported for the three months ended September 30, 2001. Research and development expenses for the nine months ended September 30, 2002 were $4.4 million, an 80% decrease from the $22.1 million reported for the nine months ended September 30, 2001. Research and development expenses consist primarily of personnel and other expenses

14


Table of Contents

associated with developing, updating, and enhancing software. The decrease is primarily due to reductions in workforce that have occurred over the past twelve months. To date, all software development costs have been expensed in the period incurred. The Company believes that continued investment in research and development is required to remain competitive and does not expect significant changes in research and development expenses in the coming quarter.

     In process research & development. The Company expensed approximately $399,000 and $2.3 million of in-process research and development for the nine months ended September 30, 2002 and September 30, 2001, respectively. No Charges were taken in the three months ended September 30, 2002 and $2.3 million was charged during the three months ended September 30, 2001. The in-process research and development expensed in 2002 was acquired as a result of the InfoPrise purchase in February 2002. The in-process research and development expensed in 2001 was acquired as a result of the NexPrise, Inc. purchase in August 2001.

     Sales and marketing. Sales and marketing expenses for the three months ended September 30, 2002 were $1.3 million, a 22% decrease from the $1.6 million reported for the three months ended September 30, 2001. Sales and marketing expenses for the nine months ended September 30, 2002 were $4.6 million, a 49% decrease from the $9.0 million reported for the nine months ended September 30, 2001. Sales and marketing expenses consist primarily of payroll and related expenses for personnel engaged in enterprise sales activities and enterprise account management, as well as travel and promotional expenses. The decrease was primarily due to the reductions in workforce that occurred over the past twelve months and decreased marketing efforts. The Company expects sales and marketing expenses to decrease further in the near term as reductions in force carried out in September 2002 take effect.

     General and administrative. General and administrative expenses for the three months ended September 30, 2002 were $1.1 million, a 55% decrease from the $2.5 million reported for the three months ended September 30, 2001. General and administrative expenses for the nine months ended September 30, 2002 were $4.3 million, a 63% decrease from the $11.9 million reported for the nine months ended September 30, 2001. General and administrative expenses consist primarily of salaries and benefits for finance, accounting, legal, human resources, information technology support and corporate personnel as well as fees for professional services and lease expenses. The decrease in expenses was primarily due to the reductions in workforce that have occurred over the past twelve months and lower payments for outside professional services and leases. The Company does not expect significant changes in general and administrative expenses in the coming quarters.

     Restructuring and Settlement Charges. In the three months ended September 30, 2001 the Company recorded $5.3 million of restructuring charges. These charges consisted of $1.4 million of severance and other related costs associated with the reduction in force done in connection with the acquisition of NexPrise, Inc. and $3.9 million for changes in anticipated cost recoveries related to disposal of excess facilities and equipment. In the three months ended June 30, 2001 the Company recorded $14.7 million of restructuring charges. These charges consisted of a workforce reduction, consolidation of excess facilities, write-offs and accruals with respect to certain assets and commitments, as well as termination of services with Broadlane, MarketMile and Industria.

     Interest expense. Interest expense for the three months ended September 30, 2002 was $190,000, the same as that reported for the three months ended September 30, 2001. Interest expense for the nine months ended September 30, 2002 was $559,000, a 90% decrease from the $5.4 million reported for the nine months ended September 30, 2001. Interest expense consists primarily of interest related to convertible subordinated notes issued in April 2000 and, to a lesser extent other financing arrangements. Approximately $265,000 is payable semi-annually in arrears on April 1 and October 1 of each year for interest on the subordinated notes remaining at September 30, 2002. In addition, the deferred offering costs of the notes are being amortized as interest expense ratably over the term of the notes.

     Interest income and other. Interest income and other for the three months ended September 30, 2002 was $63,000, an 87% decrease from the $495,000 reported for the three months ended September 30, 2001. Interest income and other for the nine months ended September 30, 2002 was $157,000, a 96% decrease from the $4.2 million reported for the nine months ended September 30, 2001. Interest income and other, net, has been derived primarily from earnings on investments in cash equivalents and short-term investments. The decrease was primarily attributable to lower cash, cash equivalent and investment balances and a decline in interest rates as of September 30, 2002. Interest earned is expected to decrease in the next quarter as a result of lower invested balances as well as lower interest rates.

     Investment income (loss). Investment loss for the nine months ended September 30, 2002 was $1.4 million, an 83% decrease from the $8.2 million reported for the nine months ended September 30, 2001. The investment loss for the nine months ended September 30, 2002 reflects a gain of $1.8 million from the Company’s August 2002 sale of its interest in Amphire, approximately $3.0 million of equity losses in the marketplace companies in which we have a significant ownership percentage and $186,000 of write-downs of investments accounted for using the cost method. The loss for the nine months ended September 30, 2001 was made up of

15


Table of Contents

approximately $7.3 million of equity losses in the marketplace companies in which we have a significant ownership percentage and approximately $904,000 of write-downs of investments accounted for using the cost method.

     Loss before extraordinary item. As a result of the items described above the loss before extraordinary item was approximately $2.4 million and $16.6 million for the three months ended September 30, 2002 and 2001 and $15.2 million and $74.5 million for the nine months ended September 30, 2002 and 2001. The loss before extraordinary item is expected to decline modestly in the next quarter.

     Extraordinary gain. For the nine months ended September 30, 2001, the Company repurchased approximately $241.2 million of Convertible Subordinated Notes, which represented approximately 96.5% of the outstanding Notes at December 2000. The total consideration provided by the Company for the tendered notes was approximately $71.8 million, including accrued interest. The Company recognized a gain of approximately $159.2 million on the transaction. As most of the Notes have been retired, any such future gains will be smaller.

Liquidity and Capital Resources

     As of September 30, 2002 NexPrise had approximately $11.3 million of cash, cash equivalents, short-term investments and restricted cash; working capital was approximately $9.4 million.

     Net cash used in operating activities was approximately $13.7 million for the nine months ended September 30, 2002 compared to $71.1 million of net cash used in operating activities for the nine months ended September 30, 2001. Net cash used in operating activities for the nine months ended September 30, 2002 is primarily attributable to the net loss for the period (less non-cash expenses) and to a lesser extent to an increase in other current assets and deferred revenue and decreases in other accounts payable, accrued compensation, accrued expenses and discontinued liabilities. These cash flows used in operating activities were partially offset by decreases in accounts receivable and discontinued assets. The actions taken in the past twelve months to reduce expenditures are expected to decrease the ongoing use of cash by operating activities to between $2.5 million and $3.0 million in the fourth quarter of 2002.

     Net cash provided by investing activities totaled $2.1 million for the nine months ended September 30, 2002, compared to net cash provided by investing activities of $64.1 million for the nine months ended September 30, 2001. During the nine months ended September 30, 2002, the Company had net sales and maturities of $500,000 of short-term investments and gained approximately $1.0 million in cash in the acquisition of InfoPrise.

     Net cash used in financing activities was $112,000 for the nine months ended September 30, 2002 compared to net cash used in financing activities of $61.3 million for the nine months ended September 30, 2001. Net cash used in financing activities for the nine months ended September 30, 2002 resulted primarily from the principal payments on our capital lease obligations. We do not expect future payments related to this lease. In addition, the Company used $26,000 in the nine months ended September 30, 2002 to repurchase Company stock.

     Management believes the Company has adequate cash to sustain operations through 2002 and is managing its business to achieve positive cash flow utilizing existing assets. During 2001 the Company’s commitments and liabilities were significantly reduced via restructuring events, settlements of long-term contracts and the repurchase of convertible notes at a substantial gain. In addition, the Company reduced ongoing operating expenses by renegotiating its lease commitments, reducing purchases of other services and making workforce reductions. It is the Company’s belief that the adjustments to spending that have been made, combined with receipts expected from customer contracts already in place and new customer contracts expected to be signed in 2002 and thereafter will provide the additional resources required to achieve positive cash flow. We are committed to the successful execution of our operating plan and will take further action as necessary to align our operations and reduce expenses.

     Although we expect our existing cash, cash equivalent and investment balances together with our anticipated cash flows from operations to be sufficient to meet our working capital and operating resource expenditure requirements for at least the next twelve months, higher than anticipated expenses or lower than anticipated receipts may result in lower cash, cash equivalents and investments balances than presently anticipated. After the next twelve months, we may find it necessary to obtain additional equity or debt financing. In the event additional financing is required, we may not be able to raise it on acceptable terms or at all.

Risk Factors

16


Table of Contents

     This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including those set forth in the following cautionary statements and elsewhere in this Quarterly Report on Form 10-Q. If any of the following risks were to occur, our business, financial condition or results or operations would likely suffer. In addition to other information in this Form 10-Q, the following risk factors should be carefully considered in evaluating NexPrise and its business because such factors currently may have significant impact on NexPrise’s business, operating results and financial condition.

Investment Considerations

     An investment in our securities involves significant risks, including those described below. These risks relate to our new business model, our ability to generate revenues and gain operating efficiencies, our history of losses, significant changes, our ability to hire and retain key personnel, our reliance on the hosted environment and technology provided by others, the possible delisting of our common stock, the need to respond to rapid technological change and legal claims against us.

     Our actual results may differ materially from those expressed in any forward-looking statement as a result of certain factors, including but not limited to those set forth below and included in other portions of this document.

We Have Made Substantial Changes in Our Business Model and Shut Down the Businesses That Had Provided All of Our Revenues Since Inception

     In August 2001 we used approximately $23 million in cash to acquire NexPrise, Inc. a provider of collaborative commerce software solutions. This business now provides all of our revenue; thus, management focus and operational efforts primarily support this business. Prior to this acquisition, the Company’s business model was substantially different. In December 2000, we shut down our Chemdex and Promedix marketplaces, laid off 235 employees and restructured certain operations. On April 26, 2001, we implemented another restructuring in which we terminated 170 employees, representing two-thirds of our workforce, accrued future lease costs associated with excess production equipment and facilities, and wrote off assets as well as the value of certain investments to recognize their diminished future utility to the Company. During the first six months of 2001, we ceased to provide technology and services to our remaining marketplaces, and, as part of the combination with NexPrise, Inc. we terminated additional personnel. Furthermore, in February 2002 we acquired InfoPrise, a provider of data management solutions. As a result of these and similar actions, there has been a fundamental change in our business. There can be no assurance that we will be successful in developing viable technology or a complete service offering.

Restructurings May Not Sufficiently Reduce Operating Expenses

     Our restructurings were designed to lower the cash used for operating expenses by reducing expenses for facilities, sales and marketing, hosting, professional services and marketing arrangements and significantly reducing our current employee and contractor staffing levels. While the Company has executed its restructuring plans and the restructurings have reduced cash operating expenses, our ability to ultimately generate profitable results from operations is dependent upon successful execution of our business plan, including obtaining new customers. As of September 30, 2002, we had working capital of $9.4 million and had stockholders equity of $21.1 million. During the nine months ended September 30, 2002, we used cash in operating activities of $13.7 million. There can be no assurance that we will be successful in implementing our new business plan or sufficiently reducing our operating expenses in the future. Our inability to reduce costs or to integrate our recent acquisition and develop a successful product and services offering could have a material adverse effect upon our ability to successfully transition to our new business plan and to remain in business after 2002.

We Have a Limited Operating History and an Evolving Technology and Service Offering, Which Makes it Difficult to Evaluate Our Future Prospects

     Our success is based on integrating and developing a viable technology and services offering and securing new customers. Our business model is not fully developed, not proven and depends upon our ability, among other things, to:

          develop and market technology and services solutions that achieve broad market acceptance by our customers;
 
          acquire and deploy a sufficient number of customers to achieve profitability;
 
          extend our technology to support a wide range of hardware and software to meet the needs of a large range of customers with a variety of needs;

17


Table of Contents

          acquire or license third party technologies that we require to deliver our technology and services;
 
          overcome publicity related to our public announcements of restructurings, shareholder litigation and the shutdown of our former marketplaces; and
 
          acquire customers operating in industries where we have limited experience and provide them quality technology and services.

     We may not successfully address these risks. If we do successfully address these risks, additional risks related to factors that are outside our control may prevent us from realizing sufficient revenues or profit margins to reach or sustain profitability. For example, business process solutions may experience problems with users as a result of security and privacy concerns, general reticence about technology or the Internet.

We May Not Achieve the Benefits We Expect from the Acquisitions of NexPrise and of InfoPrise and This May Have a Material Adverse Effect on the Combined Company’s Business, Financial Condition and Operating Results

     The combined company will need to overcome significant issues in order to realize any benefits or synergies from the acquisitions, including the timely, efficient and successful execution of a number of post-merger events. Key events include:

          integrating the operations of the companies;
 
          retaining and assimilating the key personnel of each company;
 
          developing a product that will be attractive to existing and potential customers; and
 
          retaining existing customers and strategic partners of each company.

     The successful execution of these post-merger events will involve considerable risk and may not be successful. These risks include:

          the potential disruption of the combined company’s ongoing business and distraction of its management;
 
          the difficulty of incorporating acquired technology and rights into the combined company’s products and services;
 
          unanticipated expenses related to technology integration;
 
          the impairment of relationships with employees and customers as a result of any integration of new management personnel; and
 
          potential unknown liabilities associated with the merger.

     The combined company may not succeed in addressing these risks or other problems encountered in connection with the mergers.

We Are Dependent on a Small Number of Customers in a Limited Number of Industries

     To date, we have derived a significant portion of our revenues from a small number of customers in two industries. Many of our customers do not have contracts that extend beyond one year. Critical to the success of the Company’s business plan will be the acquisition of new customers in other industries, increasing the number of users in our current customers and renewing current contracts. There can be no assurance that we will be successful in developing profitable relationships with new customers in new industries or that we will retain existing customers.

Legislative Actions, Higher Insurance Costs and Potential New Accounting Pronouncements May Cause our General and Administrative Expenses to Increase and Impact our Future Financial Position and Results of Operations

     In order to comply with the newly adopted Sarbanes-Oxley Act of 2002, as well as proposed changes to listing standards by NASDAQ and proposed accounting changes by the Securities and Exchange Commission, we may be required to increase our internal controls, hire additional personnel and utilize additional outside legal, accounting and advisory services, all of which will cause our general and administrative costs to increase. Insurers are also likely to increase premiums as a result of the high claims rates incurred over the past year, and so our premiums for our various insurance policies, including our directors’ and officers’ insurance policies, are likely to increase. Proposed changes to accounting rules, including legislative and other proposals to account for employee stock

18


Table of Contents

options as a compensation expense among others, could materially increase the expenses we report under generally accepted accounting principles and adversely affect our operating results.

Security Risks and Concerns May Decrease the Demand for Our Services, and Security Breaches May Disrupt Our Services or Make Them Inaccessible to Our Customers.

     Our services involve the storage and transmission of business-critical, proprietary information. If the security measures we or our third party data centers have implemented are breached, our customers could lose this information and we could be exposed to litigation and possible liability. Anyone who circumvents these security measures could misappropriate business-critical proprietary information or cause interruptions in our services or operations. In addition, computer “hackers” could introduce computer viruses into our systems or those of our customers, which could disrupt our services or make them inaccessible to customers. We may be required to expend significant capital and other resources to protect against the threat of security breaches or to alleviate problems caused by breaches. Our security measures and those that our third-party data centers provide may be inadequate to prevent security breaches, and our business and reputation will suffer if these breaches occur.

We Are Dependent Upon Outsourcing Providers for Provision of the Hosted Environment for our Customers; Connection and Performance Issues Have Occurred and May Recur

     We rely on third-party providers for our data center services, principal Internet connections and data hosting. This hosted environment is critical to the provision of our software to our customers and if the environment does not work well, is cut-off or fails, our customers are unable to use our solution; this causes great consternation among any hosted customer. We have experienced and may continue to experience interruptions and delays in service and availability for such services. We signed an agreement with a new vendor to provide the hosted environment, but the new provider has decided to exit the business. There can be no assurance that the transition to another new provider will successfully occur to the full satisfaction of our customers. Furthermore, we depend on these third party providers for prompt delivery, installation and service of software, hardware and telecommunications equipment used to deliver our products and services. Any failures, interruptions, or delays experienced or caused by these third party providers could negatively impact our relationship with users and adversely affect our brand and our business and could expose us to liabilities to third parties. In addition, because we are required in most circumstances to enter into contracts for data center space in advance of customer commitments, if we are unable to increase our customer base at the rate that we anticipate in the geographic areas in which we have contracted for space, our operating results will suffer.

     Our operations could be significantly hindered by the occurrence of a natural disaster or other catastrophic event at our company or any third party provider. Our and their operations are susceptible to outages due to fire, floods, power loss, telecommunications failures, break-ins and similar events. In addition, the majority of our and their network infrastructure is located in California, an area susceptible to earthquakes. In the recent past, the western United States (and California in particular) has experienced repeated episodes of diminished electrical power supply. As a result of these episodes, certain of our and their operations or facilities may be subject to “rolling blackouts” or other unscheduled interruptions of electrical power. The prospect of such unscheduled interruptions may continue for the foreseeable future and we are unable to predict either their occurrence, duration or cessation. We do not have, and our third party providers may not have, multiple site capacity for all of our services in the event of any such occurrence. Despite implementation of network security measures, the servers are vulnerable to computer viruses, physical and electronic break-ins, and similar disruptions from unauthorized tampering with our computer systems. In addition, systems are vulnerable to coordinated attempts to overload them with data, which could result in denial or reduction of service to some or all of our users for a period of time. Furthermore, the failure by the third party providers to provide our required data communications capacity could result in interruptions in our service. Interruptions in our service will reduce our revenues and profits, and our future revenues and profits will be harmed if our users believe that our system is unreliable or insecure. We have experienced system failures from time to time. If we experience frequent or persistent system failures, our reputation and brand could be permanently harmed. We do not carry sufficient business interruption insurance to compensate us for losses that may occur as a result of any of these events. Any such event could have a material adverse effect on our business, operating results, and financial condition.

Our Operating Results Are Highly Dependent on License and Service Revenues from Our Software Suite and Our Business Could Be Materially Harmed by Factors That Adversely Affect the Pricing and Demand for This Software Suite

     Substantially all of our license revenues have been, and the license and services revenues of the combined company continue to be, primarily derived from the license of the ipTeam™ solution. Our future operating results will depend on continued demand for ipTeam and the recently introduced nProcess Platform. ipTeam was commercially launched in 1998. If our competitors release new products that are superior to ipTeam or nProcess Platform in performance or price, or if we fail to enhance ipTeam and nProcess

19


Table of Contents

Platform in a timely manner, demand for our products may decline, and we may have to reduce the pricing of our products. A decline in demand or pricing as a result of these or other factors would significantly reduce the revenues we can expect in the future.

     In the past, many software companies have experienced delays in the commencement of commercial release of their products. To date, such delays have not had a material impact on NexPrise’s revenues. In the future, we may fail to introduce or deliver new products on a timely basis. If new releases or products are delayed or do not achieve market acceptance, we could experience customer dissatisfaction or a delay or loss of revenues. In addition, customers may delay purchases of our products in anticipation of future releases. If customers defer material orders in anticipation of new releases or new product introductions, our revenues may decline.

     Moreover, as we release enhanced versions of our products, we may not be successful in upgrading our customers who purchased previous versions of the product to the current version. We also may not be successful in selling add-on modules for our products to existing customers. Any failure to continue to upgrade existing customers’ products or sell new modules, if and when they are introduced, could negatively impact customer satisfaction and our revenues.

     As with most software companies, developing and selling a product that does not require significant customization in product features or sales process for any particular customer or set of customers is critical to our success. If we are unable to resist customer requests to individualize our product or unable to develop a repeatable sales process our revenues will suffer and our costs will increase.

The Company Has a History of Losses, No Significant Revenues and Expects to Continue to Incur Significant Operating Losses and Negative Cash Flow; We May Never Achieve or Maintain Profitability

     We have incurred substantial net losses in the past and we expect to incur net losses in future periods. We incurred a net loss of approximately $15.2 million during the nine months ended September 30, 2002 and a net loss before extraordinary items of $74.4 million during the nine months ended September 30, 2001. As of September 30, 2002 we had an accumulated deficit of approximately $610.3 million. We will need to generate significant increases in revenues to achieve and maintain profitability, and we may not be able to do so. If our revenues grow more slowly than we anticipate or if our operating expenses increase more than we expect or cannot be reduced in the event of lower revenues, our business will be significantly and adversely affected. Even if we achieve profitability in the future on a quarterly or annual basis, we may not be able to sustain or increase profitability. Failure to achieve profitability or achieve and sustain the level of profitability expected by investors and securities analysts may adversely affect the market price of our common stock.

We Operate in a New, Highly Competitive Market and Our Inability to Compete Successfully Against New Entrants and Established Companies Could Adversely Affect Our Market Share

     Our target market is rapidly evolving and highly competitive. It may be characterized by an increasing number of market entrants, as many companies may find a technological path around existing barriers to entry.

     We already have competition from a diverse group of companies, including companies such as MatrixOne and PTC. In addition, providers of various software products such as Ariba, Commerce One, Oracle, IBM and SAP may expand their product offerings to be competitive with us in the future.

     Our current and potential competitors may develop superior platforms that achieve greater market acceptance than our solution. Many of our existing and potential competitors have longer operating histories, greater name recognition, larger customer bases and significantly greater financial, technical and marketing resources than we do. Such competitors can undertake more extensive marketing campaigns for their brands, products and services, adopt more aggressive pricing policies and make more attractive offers to customers, potential employees, distribution partners, commerce companies and third-party suppliers.

     In addition, substantially all of our prospective customers have established and long-standing relationships with some of our current or potential competitors. Accordingly, we cannot be certain that we will be able to expand NexPrise’s customer and user base, or retain its current customers. We may not be able to compete successfully against our current or future competitors, which could have a material adverse effect on our business, results of operations and financial condition.

Our Financial Performance, Workforce Reduction and Acquisitions of NexPrise and InfoPrise May Adversely Affect the Morale and Performance of Our Personnel and Our Ability to Hire New Personnel

20


Table of Contents

     In connection with the evolution of our business model and in order to reduce our cash expenses, we have enacted a number of changes in personnel. This includes changes to virtually all executive management, resignation of most of the original board of directors and significant workforce reductions. The significant changes in personnel may adversely affect morale and the company’s ability to attract and retain key personnel. In addition, recent trading levels of our common stock have decreased the value of the stock options granted to employees pursuant to our stock option plan. As a result of these factors, our remaining personnel may seek employment with larger, more established companies or companies they perceive to have better prospects.

General Economic and Political Conditions May Impact Our Results

     Our revenue growth and future profitability depend on the overall demand for software and related services. This demand can be adversely affected by unfavorable economic conditions, as customers reduce or defer spending on information technology improvements. We may be especially prone to this as a result of the relatively small installed base and operating history of our products. A softening demand for software caused by a prolonged slowdown of the economy would result in decreased revenue or lower revenue growth rates and would adversely affect our operating results.

     Recent political events, including the September 11, 2001 tragedy, have put further pressure on economic conditions. The potential turmoil that may result from such events contributes to the uncertainty of the economic climate, further reducing predictability and our ability to develop and implement long-term strategic plans. The impact of these or future similar events may have a material adverse impact on our operating results and financial position

If We Fail to Comply with Nasdaq Rules, Our Common Stock May Be Delisted from The Nasdaq National Market, Which Could Eliminate the Trading Market for Our Common Stock

     If we fail to meet the criteria for continued listing on The Nasdaq National Market, our common stock may be delisted from The Nasdaq National Market. If the stock is delisted, it would significantly decrease the liquidity of an investment in NexPrise common stock. In addition, the stock may be deemed to be penny stock. If our common stock is considered penny stock, it would be subject to rules that impose additional sales practices on broker-dealers who sell our securities. For example, broker-dealers would have to make a special suitability determination for the purchaser and have received the purchaser’s written consent to the transaction prior to sale. Also, a disclosure schedule must be prepared prior to any transaction involving a penny stock and disclosure is required about sales commissions payable to both the broker-dealer and the registered representative and current quotations for the securities. Monthly statements are also required to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stock. Because of these additional obligations, some brokers may be unwilling to effect transactions in penny stocks. This could have an adverse effect on the liquidity of our common stock and the ability of investors to sell the common stock.

The Market Price Per Share of NexPrise Common Stock Following the Reverse Stock Split May Not Remain in Excess of the $1.00 Minimum Bid Price as Required by Nasdaq, as Downward Pressure May be Created by Such Split or Other Factors May Arise.

     We cannot predict whether the recently completed reverse stock split will permanently increase the market price for our common stock. The history of similar stock split combinations for companies in like circumstances is varied. There is no assurance that the market price per share of our common stock following the reverse stock split will remain in excess of the $1.00 minimum bid price as required by Nasdaq or that we will otherwise meet the requirements of Nasdaq for continued inclusion for trading on Nasdaq. A reverse stock split could negatively impact the value of our stock by allowing additional downward pressure on the stock price as its relative value becomes greater following the reverse split. In other words, the stock, at its new, higher price, has farther to fall and therefore more room for investors to short or otherwise trade the value of the stock downward. Similarly, a delisting may negatively impact the value of the stock as stocks trading on the over-the-counter market are typically less liquid and trade with larger variations between the bid and ask price. The market price of our common stock will also be based on our performance and other factors, some of which are unrelated to the number of shares outstanding. If the market price of our common stock declines, the percentage decline as an absolute number and as a percentage of our overall market capitalization may be greater than would occur in the absence of a reverse stock split. Furthermore, liquidity of our common stock could be adversely affected by the reduced number of shares that would be outstanding after the reverse stock split.

Our Business Involves a Lengthy and Unpredictable Sales Cycle

21


Table of Contents

     The sales cycle for the target customers of the software and services we provide tends to be lengthy; our sales cycle may be somewhat longer than those of our more established competitors. The unpredictability of the length of our sales cycle could make it difficult to forecast revenue and plan expenditures. Additionally, any delays in deployment of our software related to our inexperience with a type of business or the size or complexity of the account would delay our ability to recognize revenue from that account. Such delays could adversely affect our financial results.

Our Business Will Suffer If We Do Not Enhance Our Product or Introduce New Features to Meet Changing Customer Requirements

     The market for software and services is characterized by rapid technological change, frequent new hardware, software and networking product introductions and Internet-related technology enhancements, uncertain product life cycles, changes in customer demands and evolving industry standards. If we do not develop technology that can respond to these changes the probability of us obtaining new customers will be remote. In particular, we are designing our technology to support a variety of hardware, software and networking products that we believe to be proven and among the most widely used. We can make no assurances, however, that future customers will continue to use these products. Even if they do, new versions of these products are likely to be released and we will need to adapt our technology to keep pace with changes made to hardware and software configurations and network infrastructures.

     If we do not develop, license or acquire new technology, or deliver enhancements to existing products on a timely and cost-effective basis, we may be unable to meet the growing demands of potential customers. In addition, as we introduce new services or technologies into existing customer architectures, we may experience performance problems associated with incompatibility among different versions of hardware, software and networking products. To the extent that such problems occur, we may face adverse publicity, delay in market acceptance of our services or customer claims against us, any of which could harm our business.

We Anticipate Our Operating Results Will Fluctuate Significantly from Quarter-to-Quarter

     Important factors that could cause our quarterly results to fluctuate materially include:

          the timing of obtaining new customers (length of sales cycle);
 
          the timing of deploying services for new customers;
 
          the timing and magnitude of operating expenses and capital expenditures;
 
          costs related to the various third-party technologies we incorporate into our products;
 
          utilization of our leased third-party data center space and technology infrastructure;
 
          changes in our pricing policies or those of our competitors; and
 
          the amount of credits that we may be required to issue to our current customers if we fail to deliver our services pursuant to contractual arrangements.

     Due to these and other factors, quarter-to-quarter comparisons of our operating results may not be meaningful. You should not rely on our results for any one quarter as an indication of our future performance. In future quarters, our operating results may fall below the expectations of public market analysts or investors. If this occurs, the market price of our common stock would likely decline.

     Our current and future levels of operating expenses and capital expenditures are based largely on our operating plans and estimates of future billings and revenues. These expenditure levels are, to a large extent, fixed in the short term. We may not be able to adjust spending in a timely manner to compensate for any unexpected revenue shortfall, and any significant shortfall in revenue relative to planned expenditures could negatively impact our business and results of operations.

We Are Dependent on Intellectual Property and on Products Licensed or Purchased from Third Parties and are Exposed to Legal Liability for Infringement

     Our success and ability to compete depends on our ability to develop and maintain the proprietary aspects of our technology. We rely on a combination of copyright, trademark and trade secret laws and contractual restrictions to establish and protect the proprietary aspects of our technology. We seek to protect the source code for our software, documentation and other written materials under trade secret copyright laws. Finally, we seek to avoid disclosure of our intellectual property by requiring employees and consultants with access to our proprietary information to execute confidentiality agreements with us and by restricting access to our source code.

22


Table of Contents

     Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy aspects of our products or to obtain and use information that we regard as proprietary. Litigation may be necessary in the future to enforce our intellectual property rights, to protect our trade secrets, and to determine the validity and scope of the proprietary rights of others. Any resulting litigation could result in substantial costs and diversion of resources and could have a material adverse effect on our business operating results.

     Our business has involved the licensing of our technology to our customers. Pursuant to our existing licenses, we have made certain representations and warranties and agreed to indemnify our licensees against claims of infringement by third parties. Thus, we may be exposed to a significant risk of liability for intellectual property infringement claims by others. Our success and ability to compete also depend on our ability to operate without infringing upon the proprietary rights of others. In the event of a successful claim of infringement against us and our failure or inability to license the infringed technology, our business and operating results would be significantly harmed.

     As part of our normal operations, we purchase, license or lease software, hardware and networking products from third party commercial vendors. We obtain most of our components from third parties on a purchase order basis. These products may not continue to be available on commercially reasonable terms, or at all. The loss of these products could result in delays in the sale of our services until equivalent technology, if available, is identified, procured and integrated, and these delays could result in lost revenues. Some of the key components of our services are available only from sole or limited sources. For example, only hardware manufactured by two vendors is compatible with the Solaris operating system, which is a key component of our infrastructure. Further, to the extent that the vendors from whom we purchase these products increase their prices, our gross margins could be negatively affected.

Non-Compliance with Government Regulations May Subject Us to Liability

     In addition to regulations applicable to businesses generally, in connection with our former business of servicing business-to-business marketplaces, we were subject to direct regulation by governmental agencies which includes numerous laws and regulations generally applicable to the chemical, pharmaceutical, controlled substances, human and biological reagents, medical and invitro devices, nuclear chemical businesses and environmental spills, as well as U.S. import and export controls and import controls of other countries. While the shutdown of Chemdex, Promedix and SpecialtyMD may limit future regulatory and product liability risks, until all statutes of limitation have expired, certain legal risks will remain.

     We relied on our suppliers to comply with applicable local, state and federal laws regarding the labeling and the dissemination of information on any products sold that may be hazardous or present a health threat to the user. If these suppliers have failed, or we have failed to maintain the requisite records irrespective of the actions of the suppliers, or if either of us have failed to adequately comply with labeling and information dispensing requirements of local, state or federal laws, then we may be held legally responsible, since we held title to these products, and could be subject to governmental penalties or fines, as well as private lawsuits to enforce these laws. We have also relied upon our suppliers to obtain appropriate approvals for products regulated by the FDA and to comply with the requirements relating to those approvals and products. The failure of suppliers to obtain or comply with those approvals, or the failure of the product advertising or labeling to be consistent with the FDA approval for the products, or other failures by the products themselves, or our failure to keep regulatory records required by the FDA, such as complaint files, could result in costly product recalls, significant fines and judgments, civil and criminal liabilities and negative publicity. In addition, we may discover that we inadvertently sold other regulated products without a requisite license or permit or failed to fully comply with other local, state or federal laws governing these sales.

     Except as described in the next sentence, we are unaware of any current investigations, inquiries, citations, fines or allegations of violations or noncompliance relating to regulatory requirements pending by government agencies or by third parties against us. In February, 2001 we received a subpoena from the U.S. Department of Justice, Drug Enforcement Administration, for certain billing, invoice, and shipping records concerning sales to an unaffiliated purchaser. It is also possible that there may be investigations or allegations that we are not aware of or future investigations or allegations. The risk that any noncompliance may be discovered in the future is currently unknown. Although any potential impact on us for noncompliance cannot currently be established, it could result in significant civil or criminal penalties, including monetary fines and injunctions, for noncompliance and negative publicity, and seriously harm our business, revenues, results of operations and financial condition.

23


Table of Contents

Government Contracts and Compliance With Government Regulations May Subject Us to Increased Administrative Burdens and Risks That May Increase the Cost of Doing Business

     As a result of increased contracting with Federal, state and local agencies, we may become subject to additional laws and regulations not currently applicable to us thereby increasing our administrative burdens. Furthermore, we must comply with any new regulations in both Europe and the United States, as well as any other regulations adopted by other countries where we may do business. Compliance with any newly adopted laws may prove difficult and may harm our business, operating results and financial condition.

     Government entities may also terminate their contracts with us earlier than we expect which could result in revenue shortfalls. Government entities may also investigate and audit our contracts and, if any improprieties are found, we may be required to refund revenues we have received, to forego anticipated revenues and may be subject to penalties. In addition, if we fail to establish and maintain important relationships with government entities and agencies, our ability to successfully bid for future contracts may be adversely affected.

We Face Risks Associated With Stockholder and Bondholder Litigation

     Several class action lawsuits have been filed and served upon us alleging that we and certain individuals made false and misleading statements concerning our business model and earnings for fiscal 2000 and concerning our initial public offering. Although we believe that we have meritorious defenses to the actions and intend to defend the suits vigorously, we cannot predict with certainty the outcome of these lawsuits. Our defense against such lawsuits will be costly and will require a significant commitment of time and resources by our senior management.

Our Common Stock Price is Especially Volatile Which Could Result in Substantial Losses to Investors

     The stock market and specifically the stock prices of technology related companies have been very volatile. This broad market volatility and industry volatility may reduce the price of our common stock, because our business is Internet-based without regard to our operating performance. On a post reverse split basis, our common stock reached a high of $3,652.50 and traded as low as $8.85 during 2000, and had a high of $64.65 and low of $1.80 during 2001. On September 30, 2002 the last reported sales price on Nasdaq was $2.50.

     In addition, under SFAS 142, the fair value of the Company as represented by its stock price has a significant effect on the determination of any required writedown of goodwill and other tangible assets. The extent to which the Company’s stock price at the time of the next evaluation of goodwill impairment is lower than at other points in time in which the goodwill has been evaluated increases the probability of a writedown.

Item 3.    Qualitative and Quantitative Disclosure about Market Risk

Market Risk Disclosure

     The following discussion about the Company’s market risk disclosures involves forward-looking statements. Actual results could differ materially from those projected in the forward-looking statements. We are exposed to market risk related primarily to changes in interest rates. However, we do not hold derivative financial instruments for speculative or trading purposes.

Interest Rate Sensitivity

     We maintain a short-term investment portfolio consisting of mainly income securities with maturities of less than one year. These available-for-sale securities are subject to interest rate risk and will fall in value if market interest rates increase. We place our investments in instruments that meet high credit quality standards, as specified in our investment policy. We do not expect any material loss with respect to our investment portfolio. Our notes payable are at a fixed interest rate.

Foreign Currency Risk

     Our sales to-date have been made to U.S. customers and, as a result, we have not had any exposure to factors such as changes in foreign currency exchange rates or weak economic conditions in foreign markets. However, we are now selling and, in future periods, we expect to sell more in foreign markets. If our sales will be made in U.S. dollars, a strengthening of the U.S. dollar could make our products less competitive in foreign markets.

24


Table of Contents

Item 4.    Controls and Procedures

(a)  Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-14(c) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), within 90 days prior to the filing date of this report. Based on their evaluation, our principal executive officer and principal accounting officer concluded that our disclosure controls and procedures are effective in ensuring that we are able to gather, analyze and disclose on a timely basis all information that is required to be disclosed in our Exchange Act reports.

(b)  There have been no significant changes (including corrective actions with regard to significant deficiencies or material weaknesses) in our internal controls or in other factors that could significantly affect these controls subsequent to the date of the evaluation referenced in paragraph (a) above.

PART II.    OTHER INFORMATION

Item 1.    Legal Proceedings

     In March 2001, several lawsuits were filed in United States District Court for the Northern District of California against the Company and certain of its officers and directors on behalf of putative classes of persons who purchased the Company’s securities during time periods from December 1999 through December 6, 2000. One of the lawsuits also names as a defendant the lead underwriter for the Company’s offering of convertible notes. The lawsuits generally allege that the Company and certain individuals violated federal securities laws by making false and misleading statements during 2000, including in the Company’s registration statement for its convertible notes offering. These lawsuits have been consolidated as In re Ventro Corp. Sec. Litig., Master File No. Civ. 01-1287 SBA, and a consolidated complaint was filed. Defendants have filed motions to dismiss. No discovery has taken place, and the Court has not set a trial date. The Company believes that the claims are without merit and intends to defend the case vigorously.

     In August 2001, Chadwell v Byers, Case No. CV800814, a putative stockholder derivative suit was filed in California Superior Court, Santa Clara County against certain of the Company’s present and former officers and directors, alleging breaches of fiduciary duty and insider trading. The Company is named solely as a nominal defendant against whom no recovery is sought. After a demurrer was sustained with leave to amend, the parties stipulated to a stay of proceedings pending resolution of the IN re Ventro Corp. Sec. Litig. Federal consolidated action.

     Also in March 2001 a stockholder class action complaint was filed in the United States District Court for the Southern District of New York against us, several of our officers and directors, and the underwriters of our initial public offering, Kassin v. Ventro Corp. et al., Index No. 01-CV-3450 (SAS). The class action has been consolidated for pre-trial purposes with more than one thousand other actions, filed against more than 300 other issuers of securities, affiliated individuals and dozens of underwriters of the securities offerings in In Re Initial Public Offering Securities Litigation, 21 MC 92 (SAS). The plaintiffs allege that the prospectus for the initial public offering of Chemdex securities, incorporated in the Registration Statement on Form S-1 filed with the Securities and Exchange Commission, was materially false and misleading because it failed to disclose, among other things, that the underwriters had made secret arrangements for aftermarket purchases of the securities and made arrangements for excessive and improper underwriters’ compensation in the form of increased brokerage commissions. Plaintiffs are claiming damages of an unspecified amount based on the subsequent decline in the market price of the Company’s shares below their original offering price. The litigation is in an early phase and no substantive rulings have been issued by the Court. Although we believe that we have meritorious defenses to the action and intend to defend the suit vigorously, we cannot predict with certainty the outcome of this lawsuit. Our defense against such lawsuits will be costly and may require a significant commitment of time and resources by our senior management.

     The Company is a party to various claims in the ordinary course of business. Although the results of litigation and claims cannot be predicted with certainty, the Company believes the final outcome of such matters will not have a material adverse effect on the Company’s financial position, results of operations or cash flows.

25


Table of Contents

Item 2.    Changes in Securities and Use of Proceeds

     None

Item 3.    Defaults upon Senior Securities

     None

Item 4.    Submission of Matters to a Vote of Securities Holders

     None

Item 5.    Other Information

     None

Item 6.    Exhibits and Reports on Form 8-K

(a)    Exhibits. The following is a list of exhibits filed as part of this Report on Form 10-Q. Where indicated by footnote, exhibits that were previously filed are incorporated by reference.
     
Exhibit    
Number   Description

 
99.1   Certification by Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
99.2   Certification by Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


(b)      Reports on Form 8-K:
    (1)    On September 3, 2002, NexPrise filed a report on Form 8-K announcing the sale of its interest in Amphire Solutions.

26


Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on October 31, 2002.
     
  NEXPRISE, INC.
 
  By:   /s/    JEROME E. NATOLI
Jerome E. Natoli
Chief Financial Officer

27


Table of Contents

CERTIFICATIONS

I, Ted Drysdale, certify that:

1.    I have reviewed this quarterly report on Form 10-Q of NexPrise, Inc. (the “Registrant”);

2.    Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; and

3.    Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report.

4.    I:
               
  (A)  am responsible for establishing and maintaining internal controls;
               
  (B)  have designed such internal controls to ensure that material relating to the Registrant and its consolidated subsidiaries is made known to me by others within those entities for the period in which the Report was prepared;
 
  (C)  have evaluated the effectiveness of the Registrant’s internal controls as of October 21, 2002, and
 
  (D)  have presented in the Report my conclusions about the effectiveness of the Registrant’s internal controls based upon my evaluation as of October 21, 2002.

5.    I have disclosed to the Registrant’s auditors and the audit committee of the Registrant’s board of directors the following:
               
  (A)  all significant deficiencies in the design or operation of internal controls which could adversely affect the Registrant’s ability to record, process, summarize and report financial data and have identified for the Registrant’s auditors any material weaknesses in internal controls; and
 
  (B)  any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal controls.

6.    I have indicated in the Report whether or not there were significant changes in internal controls or in other factors that could significantly affect the internal controls subsequent to the date of their evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
   
Date: October 31, 2002 /s/    Ted Drysdale
Ted Drysdale
President and Chief Executive Officer

28


Table of Contents

***********

I, Jerome E. Natoli, certify that:

1.    I have reviewed this quarterly report on Form 10-Q of NexPrise, Inc. (the “Registrant”);

2.    Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; and

3.    Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report.

4.    I:
               
  (A)  am responsible for establishing and maintaining internal controls;
 
  (B)  have designed such internal controls to ensure that material relating to the Registrant and its consolidated subsidiaries is made known to me by others within those entities for the period in which the Report was prepared;
 
  (C)  have evaluated the effectiveness of the Registrant’s internal controls as of October 21, 2002, and
 
  (D)  have presented in the Report my conclusions about the effectiveness of the Registrant’s internal controls based upon my evaluation as of October 21, 2002.

5.    I have disclosed to the Registrant’s auditors and the audit committee of the Registrant’s board of directors the following:
               
  (A)  all significant deficiencies in the design or operation of internal controls which could adversely affect the Registrant’s ability to record, process, summarize and report financial data and have identified for the Registrant’s auditors any material weaknesses in internal controls; and
 
  (B)  any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal controls.

6.    I have indicated in the Report whether or not there were significant changes in internal controls or in other factors that could significantly affect the internal controls subsequent to the date of their evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
   
Date: October 31, 2002 /s/    Jerome E. Natoli
Jerome E. Natoli
Chief Financial Officer

29


Table of Contents

EXHIBIT INDEX

     
Exhibit    
Number   Description

 
99.1   Certification by Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
99.2   Certification by Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

30